Chee Kong Choo

Insider Reports History

Location
Singapore, Singapore
Signature
/s/ Chee Kong Choo
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chee Kong Choo:

Company Role Class Num Shares Value Price $ Report Date Ownership
CytoMed Therapeutics Ltd Director, 10%+ Owner Ordinary Shares, no par value per share 410,515 31 Mar 2023 Indirect

Insider Reports Filed by Chee Kong Choo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GDTC CytoMed Therapeutics Ltd 31 Mar 2023 0 $0 3 Director, 10%+ Owner 14 Apr 2023, 16:59